Arch Therapeutics Inc (ARTH)

[Snowy_Owl]

From the proxy filing for September 29, 2022 annual meeting. As of now this is where I stand.

1. Elect four directors – Yes
2. Approve a reverse stock split of not less than 1-for-100 and not greater than 1-for-200 – No
3. Approve an increase in the number of authorized shares of common stock – No
4. Approve, on an advisory basis, the compensation of Executive Officers – No
5. Approve, on an advisory basis, how frequently stockholders believe we should conduct an advisory vote on the compensation of our Named Executive Officers – No
6. Approve a proposal to grant discretionary authority to adjourn the Meeting, if necessary, to solicit additional proxies – No
7. Ratify the appointment of Baker Tilly as independent auditors – Yes

Sell the company for what we can get. Arch Therapeutics does not qualify for life support at shareholders' expense.